Evidence map›Paper›PMID 22808206›Full record

ArticlePloS one2012

Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.

Candice A Johnson, Yulia Y Kleshchenko, Adaeze O Ikejiani, Aniekanabasi N Udoko, Tatiana C Cardenas, Siddharth Pratap, Mark A Duquette, Maria F Lima, Jack Lawler, Fernando Villalta and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  5. Tumor-Suppressive Cross-Linking of Anti-International journal of molecular sciences · 2024
    Article
  6. The many faces of parasite calreticulin.Frontiers in immunology · 2023
    Review
  7. Article
  8. Review
  9. Interaction With the Extracellular Matrix Triggers Calcium Signaling inFrontiers in cellular and infection microbiology · 2021
    Article
  10. International journal of molecular sciences · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Candice A JohnsonDepartment of Microbiology and Immunology, Meharry Medical College, Nashville, Tennessee, United States of America.
Yulia Y Kleshchenko
Adaeze O Ikejiani
Aniekanabasi N Udoko
Tatiana C Cardenas
Siddharth Pratap
Mark A Duquette
Maria F Lima
Jack Lawler
Fernando Villalta
Pius N Nde
Meharry Medical College · USBeth Israel Deaconess Medical Center · USNaval Medical Research Command · US

Funding

VITAMIN D DEFICIENCY AND INCREASED RISK OF UTERINE FIBROIDS IN AFRICAN AMERICANSG12RR003032 · NCRR · MEHARRY MEDICAL COLLEGE · PI RILEY, WAYNE JOSEPH · 1985 to 2011
$27.4M
Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · PI MURRAY, JOHN J. · 2009 to 2011
$12.9M
MOLECULAR PARASITOLOGY TRAINING PROGRAMT32AI007281 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 1985 to 2025
$3.2M
Molecular Analysis of Trypanosome InfectionSC1AI080580 · NIAID · MEHARRY MEDICAL COLLEGE · PI VILLALTA, FERNANDO · 2008 to 2010
$1.1M
Novel trypanosome receptor for thrombospondin-1SC2AI083925 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 2009 to 2011
$435k
NCRR NIH HHS 5 U54 RR026140-03NCRR NIH HHS G12 RR003032NCRR NIH HHS G12RR003032NCRR NIH HHS U54 RR026140NIAID NIH HHS 5T32 AI007281-23NIAID NIH HHS AI080580NIAID NIH HHS SC1 AI080580NIAID NIH HHS SC2 AI083925NIAID NIH HHS SC2AI083925NIAID NIH HHS T32 AI007281NIGMS NIH HHS GM05999NIMHD NIH HHS U54 MD007593
6 · The paper itself

Abstract

Trypanosoma cruzi causes Chagas disease, which is a neglected tropical disease that produces severe pathology and mortality. The mechanisms by which the parasite invades cells are not well elucidated. We recently reported that T. cruzi up-regulates the expression of thrombospondin-1 (TSP-1) to enhance the process of cellular invasion. Here we characterize a novel TSP-1 interaction with T. cruzi that enhances cellular infection. We show that labeled TSP-1 interacts specifically with the surface of T. cruzi trypomastigotes. We used TSP-1 to pull down interacting parasite surface proteins that were identified by mass spectrometry. We also show that full length TSP-1 and the N-terminal domain of TSP-1 (NTSP) interact with T. cruzi surface calreticulin (TcCRT) and other surface proteins. Pre-exposure of recombinant NTSP or TSP-1 to T. cruzi significantly enhances cellular infection of wild type mouse embryo fibroblasts (MEF) compared to the C-terminal domain of TSP-1, E3T3C1. In addition, blocking TcCRT with antibodies significantly inhibits the enhancement of cellular infection mediated by the TcCRT-TSP-1 interaction. Taken together, our findings indicate that TSP-1 interacts with TcCRT on the surface of T. cruzi through the NTSP domain and that this interaction enhances cellular infection. Thus surface TcCRT is a virulent factor that enhances the pathogenesis of T. cruzi infection through TSP-1, which is up-regulated by the parasite.

Indexed as

AnimalsCalreticulinCell MembraneChagas DiseaseCloning, MolecularImmunoprecipitationLife Cycle StagesMiceMice, Inbred C57BLProtein BindingStaining and LabelingThrombospondin 1Trypanosoma cruziCalreticulinThrombospondin 1

Identifiers

PMID22808206
PMCPMC3394756
OpenAlexW2144225116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.